FDA APPROVES CREAM FOR TREATMENT OF ATOPIC DERMATITIS

Stiefel Laboratories has announced that its new product for treating atopic dermatitis, MimyX Cream, has been approved by the FDA.

MimyX Cream is a topical nonsteroidal treatment for atopic dermatitis that can be used in patients of all ages. The cream restores the natural structure and components of the stratum corneum, the outermost layer of the skin, which helps repair and restore skin barrier function without adversely affecting the patient's immune system.